BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24349488)

  • 1. PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity.
    Errafiy R; Aguado C; Ghislat G; Esteve JM; Gil A; Loutfi M; Knecht E
    PLoS One; 2013; 8(12):e83318. PubMed ID: 24349488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner.
    Joshi S; Singh AR; Durden DL
    J Biol Chem; 2014 Aug; 289(33):22785-22797. PubMed ID: 24982421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells.
    Shin SY; Lee KS; Choi YK; Lim HJ; Lee HG; Lim Y; Lee YH
    Carcinogenesis; 2013 Sep; 34(9):2080-9. PubMed ID: 23689352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN protects kidney against acute kidney injury by alleviating apoptosis and promoting autophagy via regulating HIF1-α and mTOR through PI3K/Akt pathway.
    Wang Y; Wang X; Wang H; Bao J; Jia N; Huang H; Li A
    Exp Cell Res; 2021 Sep; 406(1):112729. PubMed ID: 34242625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells.
    Kim MS; Park MJ; Moon EJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH
    Cancer Res; 2005 Feb; 65(3):686-91. PubMed ID: 15705860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
    Steelman LS; Navolanic PM; Sokolosky ML; Taylor JR; Lehmann BD; Chappell WH; Abrams SL; Wong EW; Stadelman KM; Terrian DM; Leslie NR; Martelli AM; Stivala F; Libra M; Franklin RA; McCubrey JA
    Oncogene; 2008 Jul; 27(29):4086-95. PubMed ID: 18332865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
    Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
    Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA
    Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑494 promotes the proliferation and migration of human glioma cancer cells through the protein kinase B/mechanistic target of rapamycin pathway by phosphatase and tensin homolog expression.
    Han K; Li ZJ; Sun P
    Oncol Rep; 2019 Jan; 41(1):351-360. PubMed ID: 30365133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway.
    Han X; Zhang YL; Lin QY; Li HH; Guo SB
    Cell Biol Toxicol; 2023 Oct; 39(5):2113-2131. PubMed ID: 35218467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
    Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway.
    Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
    Aging (Albany NY); 2018 Aug; 10(8):2113-2121. PubMed ID: 30153654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity.
    Tibarewal P; Zilidis G; Spinelli L; Schurch N; Maccario H; Gray A; Perera NM; Davidson L; Barton GJ; Leslie NR
    Sci Signal; 2012 Feb; 5(213):ra18. PubMed ID: 22375056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt and autophagy cooperate to promote survival of drug-resistant glioma.
    Fan QW; Cheng C; Hackett C; Feldman M; Houseman BT; Nicolaides T; Haas-Kogan D; James CD; Oakes SA; Debnath J; Shokat KM; Weiss WA
    Sci Signal; 2010 Nov; 3(147):ra81. PubMed ID: 21062993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy.
    Zhao J; Zhai B; Gygi SP; Goldberg AL
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15790-7. PubMed ID: 26669439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.
    Park S; Zhao D; Hatanpaa KJ; Mickey BE; Saha D; Boothman DA; Story MD; Wong ET; Burma S; Georgescu MM; Rangnekar VM; Chauncey SS; Habib AA
    Cancer Res; 2009 May; 69(10):4107-11. PubMed ID: 19435890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.